Literature DB >> 20190784

Type 1 diabetes.

Paul Burn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20190784     DOI： 10.1038/nrd3097

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  6 in total

1.  Combination therapy with a dipeptidyl peptidase-4 inhibitor and a proton pump inhibitor restores normoglycaemia in non-obese diabetic mice.

Authors:  W L Suarez-Pinzon; G S Cembrowski; A Rabinovitch
Journal:  Diabetologia       Date:  2009-05-20       Impact factor: 10.122

2.  The accelerating epidemic of childhood diabetes.

Authors:  Dana Dabelea
Journal:  Lancet       Date:  2009-05-27       Impact factor: 79.321

Review 3.  A role for islet neogenesis in curing diabetes.

Authors:  G L Pittenger; D Taylor-Fishwick; A I Vinik
Journal:  Diabetologia       Date:  2009-03-07       Impact factor: 10.122

4.  What will it take to get therapies approved for type 1 diabetes?

Authors:  Alexander Fleming
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

5.  Pregnancy-induced rise in serum C-peptide concentrations in women with type 1 diabetes.

Authors:  Lene Ringholm Nielsen; Jens F Rehfeld; Ulrik Pedersen-Bjergaard; Peter Damm; Elisabeth R Mathiesen
Journal:  Diabetes Care       Date:  2009-02-24       Impact factor: 19.112

6.  Combination therapy with glucagon-like peptide-1 and gastrin restores normoglycemia in diabetic NOD mice.

Authors:  Wilma L Suarez-Pinzon; Robert F Power; Yanhua Yan; Clive Wasserfall; Mark Atkinson; Alex Rabinovitch
Journal:  Diabetes       Date:  2008-10-03       Impact factor: 9.461
  6 in total
  9 in total

1.  Deal watch: CureDM licenses regenerative diabetes therapy to Sanofi-Aventis.

Authors: 
Journal:  Nat Rev Drug Discov       Date:  2010-06       Impact factor: 84.694

2.  Supramolecular insulin assembly II for a sustained treatment of type 1 diabetes mellitus.

Authors:  Sarika Gupta; Tandrika Chattopadhyay; Mahendra Pal Singh; Avadhesha Surolia
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-13       Impact factor: 11.205

Review 3.  Are Regulatory T Cells Defective in Type 1 Diabetes and Can We Fix Them?

Authors:  Anabelle Visperas; Dario A A Vignali
Journal:  J Immunol       Date:  2016-11-15       Impact factor: 5.422

4.  GPS-MBA: computational analysis of MHC class II epitopes in type 1 diabetes.

Authors:  Ruikun Cai; Zexian Liu; Jian Ren; Chuang Ma; Tianshun Gao; Yanhong Zhou; Qing Yang; Yu Xue
Journal:  PLoS One       Date:  2012-03-27       Impact factor: 3.240

Review 5.  In Quest for Improved Drugs against Diabetes: The Added Value of X-ray Powder Diffraction Methods.

Authors:  Fotini Karavassili; Alexandros Valmas; Stavroula Fili; Christos D Georgiou; Irene Margiolaki
Journal:  Biomolecules       Date:  2017-08-22

6.  Dietary Cows' Milk Protein A1 Beta-Casein Increases the Incidence of T1D in NOD Mice.

Authors:  Joanne S J Chia; Jennifer L McRae; Ashwantha Kumar Enjapoori; Christophe M Lefèvre; Sonja Kukuljan; Karen M Dwyer
Journal:  Nutrients       Date:  2018-09-12       Impact factor: 5.717

7.  Incretin-based therapies for patients with type 1 diabetes: a meta-analysis.

Authors:  Lili Liu; Zhuo Shao; Ying Xia; Jiabi Qin; Yang Xiao; Zhiguang Zhou; Zubing Mei
Journal:  Endocr Connect       Date:  2019-03       Impact factor: 3.335

8.  Feasibility of Localized Metabolomics in the Study of Pancreatic Islets and Diabetes.

Authors:  Oscar Alcazar; Luis F Hernandez; Ashley Tschiggfrie; Michael J Muehlbauer; James R Bain; Peter Buchwald; Midhat H Abdulreda
Journal:  Metabolites       Date:  2019-09-29

9.  Standardized GMP-compliant scalable production of human pancreas organoids.

Authors:  Marta Dossena; Roberta Piras; Alessandro Cherubini; Mario Barilani; Erica Dugnani; Francesca Salanitro; Till Moreth; Francesco Pampaloni; Lorenzo Piemonti; Lorenza Lazzari
Journal:  Stem Cell Res Ther       Date:  2020-03-04       Impact factor: 6.832
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.